Recurrence of tuberculosis in a low-incidence setting
- PMID: 18829676
- DOI: 10.1183/09031936.00104108
Recurrence of tuberculosis in a low-incidence setting
Abstract
Recurrence of active tuberculosis following treatment of an initial disease episode can occur due to endogenous re-activation or exogenous re-infection. Cases of recurrent tuberculosis in the Australian state of New South Wales between 1994 and 2006 were identified by data linkage analysis with confirmatory review of case notes. Patients with more than one culture-positive disease episode during that time period who had completed treatment for the initial disease episode were included. Genotyping of Mycobacterium tuberculosis was used to determine whether recurrence was likely to be due to re-activation or re-infection. There were 5,723 tuberculosis notifications between 1994 and 2006, 3,731 of which were culture-positive. Fifteen (0.4%) patients had recurrent culture-positive disease over a mean 5.7 yrs of follow-up (crude annual incidence 71 per 100,000 population). Recurrent tuberculosis was attributable to re-activation (indistinguishable strains) in 11 (73%) cases and to re-infection (different strains) in four (27%). In a low-incidence setting of tuberculosis, a control programme incorporating directly observed therapy for active disease resulted in a very low rate of recurrent tuberculosis over a long period of follow-up. Re-infection is less likely than re-activation, but still contributes significantly to the number of cases with recurrent disease.
Similar articles
-
Recurrent tuberculosis in Denmark: relapse vs. re-infection.Int J Tuberc Lung Dis. 2010 Apr;14(4):447-53. Int J Tuberc Lung Dis. 2010. PMID: 20202303
-
Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis.Am J Respir Crit Care Med. 2005 Jun 15;171(12):1430-5. doi: 10.1164/rccm.200409-1200OC. Epub 2005 Apr 14. Am J Respir Crit Care Med. 2005. PMID: 15831840
-
Exogenous re-infection as a cause of recurrent tuberculosis in a low-incidence area.Int J Tuberc Lung Dis. 2003 Feb;7(2):145-52. Int J Tuberc Lung Dis. 2003. PMID: 12588015
-
The management of tuberculosis: epidemiology, resistance and monitoring.Dan Med Bull. 2010 Nov;57(11):B4213. Dan Med Bull. 2010. PMID: 21055374 Review.
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
Cited by
-
How host heterogeneity governs tuberculosis reinfection?Proc Biol Sci. 2012 Jun 22;279(1737):2473-8. doi: 10.1098/rspb.2011.2712. Epub 2012 Feb 22. Proc Biol Sci. 2012. PMID: 22357260 Free PMC article.
-
Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria.Clin Microbiol Rev. 2016 Apr;29(2):239-90. doi: 10.1128/CMR.00055-15. Clin Microbiol Rev. 2016. PMID: 26912567 Free PMC article. Review.
-
Exogenous Reinfection as a Cause of Late Recurrent Tuberculosis in the United States.Ann Am Thorac Soc. 2015 Nov;12(11):1619-26. doi: 10.1513/AnnalsATS.201507-429OC. Ann Am Thorac Soc. 2015. PMID: 26325356 Free PMC article.
-
Models to understand the population-level impact of mixed strain M. tuberculosis infections.J Theor Biol. 2011 Jul 7;280(1):88-100. doi: 10.1016/j.jtbi.2011.04.011. Epub 2011 Apr 16. J Theor Biol. 2011. PMID: 21514304 Free PMC article.
-
Tuberculosis in Canada, 2016.Can Commun Dis Rep. 2018 Mar 1;44(3-4):75-81. doi: 10.14745/ccdr.v44i34a01. eCollection 2018 Mar 1. Can Commun Dis Rep. 2018. PMID: 31007614 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical